Synthesis of Some New Barbituric Acid Linked Quinoline-1,2,3-triazole Hybrids as Dual EGFR/VEGFR-2 Inhibitors.

A method was proposed for the synthesis of some new molecular hybrids containing quinoline, 1,2,3-triazole and barbituric acid residues via Knoevenagel condensation, O-prorgylation and copper(I)-catalyzed azide alkyne cycloaddition reactions. The fourteen compounds were screened for the anticancer activity against MCF-7, MDA-MB-468 and MDA-MB-231 cell lines using MTT assay. Some compounds were screened for inhibitory activity against tyrosine kinase EGFR. Finally, in silico studies like molecular docking on EGFR and VEGFR-2 and ADMET have supported the in vitro results. [ABSTRACT FROM AUTHOR]